BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 29530796)

  • 1. Testosterone replacement therapy: For whom, when and how?
    Tsametis CP; Isidori AM
    Metabolism; 2018 Sep; 86():69-78. PubMed ID: 29530796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
    Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
    J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
    Lunenfeld B; Mskhalaya G; Zitzmann M; Arver S; Kalinchenko S; Tishova Y; Morgentaler A
    Aging Male; 2015 Mar; 18(1):5-15. PubMed ID: 25657080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical hypogonadism and androgen replacement therapy: an overview.
    Ohl DA; Quallich SA
    Urol Nurs; 2006 Aug; 26(4):253-9, 269; quiz 260. PubMed ID: 16939042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy.
    Yeap BB; Grossmann M; McLachlan RI; Handelsman DJ; Wittert GA; Conway AJ; Stuckey BG; Lording DW; Allan CA; Zajac JD; Burger HG
    Med J Aust; 2016 Aug; 205(4):173-8. PubMed ID: 27510348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone deficiency in older men: a problem worth treating.
    McHenry Martin C
    Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
    Hassan J; Barkin J
    Can J Urol; 2016 Feb; 23(Suppl 1):20-30. PubMed ID: 26924592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone Replacement Therapy in Males].
    Zitzmann M
    Dtsch Med Wochenschr; 2018 Sep; 143(19):1405-1416. PubMed ID: 30231287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of Testosterone Therapy.
    Lee OD; Tillman K
    Am J Mens Health; 2016 Jan; 10(1):68-72. PubMed ID: 25398416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacing testosterone in men.
    Drug Ther Bull; 1999 Jan; 37(1):3-6. PubMed ID: 10562768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset hypogonadism: metabolic impact.
    Grossmann M; Ng Tang Fui M; Cheung AS
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.